7TM Models in Structure‐based Drug Design
Frank E. Blaney, Anna‐Maria Capelli, Giovanna Tedesco · Methods and principles in medicinal chemistry · 2006
This chapter contains sections titled: Introduction Early Models of 7TM Receptors Third Generation 7TM Models Docking Ligands into Receptor Models Designing 5-HT2C Selective Antagonists Even Wrong Models Can be Useful: The Importance of SDM Studies Fourth Generation Models Revisiting the 5-HT2C Antagonist Binding Site The Inclusion of Extracellular Loops in 7TM Models Switching Selectivity in Neurokinin Antagonists Homology (Fifth Generation) Models of 7TM Receptors “Ligand-based” Design of 7TM Receptor Compounds Pharmacophores Often do NOT Work Refinement of 7TM Pharmacophores Using Current Receptor Models Optimizing Properties of the CCR2 Antagonists Some General Ligand Considerations When Docking What the Future Holds Abbreviations and Nomenclature
Cited by 3 works. doi:10.1002/3527608249.ch11